Solomon Moshkevich Natera, Inc. (NTRA) insider trading activity

Solomon Moshkevich is PRESIDENT, CLINICALDIAGNOSTICS of Natera, Inc.. Currently has a direct ownership of 168,197 shares of NTRA, which is worth approximately $34.4 Million. The most recent transaction as insider was on Jan 14, 2026, when has been sold 44,698 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 168K

43.07% 3M change

1.6% 12M change

Total Value Held $34.4 Million

Solomon Moshkevich Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 14 2026	BUY Grant, award, or other acquisition	-	44,698 Added 21.0%	168,197 Common Stock
Jan 02 2026	SELL Open market or private sale	$675,424 $228.88 p/Share	2,951 Reduced 2.33%	123,499 Common Stock
Dec 15 2025	SELL Bona fide gift	-	115 Reduced 0.09%	126,450 Common Stock
Dec 12 2025	SELL Bona fide gift	-	180 Reduced 0.17%	108,881 Common Stock
Dec 12 2025	SELL Open market or private sale	$1,082,725 $230.76 p/Share	4,692 Reduced 3.98%	113,065 Common Stock
Dec 12 2025	BUY Exercise of conversion of derivative security	$214,585 $9.59 p/Share	22,376 Added 15.02%	126,565 Common Stock
Dec 01 2025	SELL Open market or private sale	$714,570 $238.19 p/Share	3,000 Reduced 2.68%	109,061 Common Stock

Nov 03 2025	SELL Open market or private sale	$596,880 $198.96 p/Share	3,000 Reduced 2.61%	112,061 Common Stock
Oct 28 2025	SELL Open market or private sale	$229,369 $191.46 p/Share	1,198 Reduced 1.03%	115,061 Common Stock
Oct 27 2025	SELL Open market or private sale	$193,858 $192.32 p/Share	1,008 Reduced 0.86%	116,259 Common Stock
Oct 21 2025	SELL Open market or private sale	$54,881 $187.95 p/Share	292 Reduced 0.25%	117,267 Common Stock
Oct 01 2025	SELL Open market or private sale	$479,580 $159.86 p/Share	3,000 Reduced 2.49%	117,559 Common Stock
Sep 15 2025	SELL Bona fide gift	-	300 Reduced 0.25%	120,559 Common Stock
Sep 02 2025	SELL Open market or private sale	$499,800 $166.6 p/Share	3,000 Reduced 2.42%	120,859 Common Stock
Aug 14 2025	SELL Open market or private sale	$136,010 $155.44 p/Share	875 Reduced 0.7%	123,859 Common Stock
Aug 12 2025	BUY Grant, award, or other acquisition	-	1,675 Added 1.33%	124,734 Common Stock
Aug 01 2025	SELL Open market or private sale	$399,840 $133.28 p/Share	3,000 Reduced 2.38%	123,059 Common Stock
Jul 28 2025	SELL Open market or private sale	$308,420 $139.81 p/Share	2,206 Reduced 1.72%	126,059 Common Stock
Jul 21 2025	SELL Open market or private sale	$40,533 $139.29 p/Share	291 Reduced 0.23%	128,265 Common Stock
Jul 01 2025	SELL Open market or private sale	$498,689 $166.23 p/Share	3,000 Reduced 2.25%	130,205 Common Stock
Jun 02 2025	SELL Open market or private sale	$473,250 $157.75 p/Share	3,000 Reduced 2.2%	133,205 Common Stock
May 27 2025	SELL Open market or private sale	$258,645 $156.85 p/Share	1,649 Reduced 1.27%	128,556 Common Stock
May 01 2025	SELL Open market or private sale	$451,200 $150.4 p/Share	3,000 Reduced 2.16%	136,205 Common Stock
Apr 28 2025	SELL Bona fide gift	-	75 Reduced 0.05%	139,205 Common Stock
Apr 28 2025	SELL Open market or private sale	$335,709 $152.18 p/Share	2,206 Reduced 1.56%	139,280 Common Stock

Solomon Moshkevich

PRESIDENT, CLINICALDIAGNOSTICS

Austin, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTRA shares.

Notify only if

Value

Insider Trading

Get notified when an Natera, Inc. insider buys or sells NTRA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Natera, Inc.

Track Activities on NTRA

Account